Financial Year |
March 31 2023 |
Monetary Funds |
659,533,727.23 |
Held-for-trading Financial Assets |
207,856,616.70 |
Notes Receivable |
240,114,600.14 |
Accounts Receivable |
332,173,888.42 |
Advances to Suppliers |
2,818,610.95 |
Other Receivables |
4,462,233.36 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
352,868,074.35 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
9,654,320.40 |
Total Current Assets |
1,816,005,566.51 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
57,219,760.55 |
Investment Properties |
-- |
Fixed Assetes |
161,345,211.55 |
Under-construction Projects |
50,693,853.84 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
14,127,490.40 |
R&D expenses |
-- |
Goodwill |
86,389,400.19 |
Long-Term Deferred and Prepaid Expenses |
5,541,744.70 |
Deferred Income Tax Assets |
13,751,112.16 |
Other Non-Current Assets |
894,493.98 |
Sub-Total of Non-Current Assets |
412,906,218.84 |
Total Assets |
2,228,911,785.35 |
Short-Term Loans |
40,000,000.00 |
Trading Financial liabilities |
-- |
Notes Payable |
233,015,837.04 |
Accounts Payable |
158,267,328.60 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
22,389,127.00 |
Taxes Payable |
3,914,034.69 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
17,094,371.20 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
5,297,954.84 |
Other Current Liabilities |
1,426,986.09 |
Sub-Total of Current Liabilities |
481,813,821.14 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
15,707,659.83 |
Total Liabilities |
497,521,480.97 |
Paid-In Capital(Or Share Stock) |
262,145,768.00 |
Capital Surplus |
765,792,544.39 |
Surplus Reserve |
75,126,400.23 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
628,579,179.29 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,731,390,304.38 |
Owner's Equity(Stockholder's Equity) |
1,731,390,304.38 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
2,228,911,785.35 |